In summary, our study suggested the mechanisms and roles of PRMT5 in promoting ovarian cancer growth, and targeting PMRT5 could be provided new potential clues for the treatment of ovarian cancer. This evidence concerns the gene PRMT5 and ovarian carcinoma.